Status:
COMPLETED
A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo
Lead Sponsor:
Pfizer
Conditions:
Osteoporosis
Eligibility:
FEMALE
55-70 years
Phase:
NA
Brief Summary
This methodology trial will be conducted in patients with osteoporosis and will measure the changes in bone quality parameters, micro- and macroarchitecture, bone biomarkers and bone density following...
Eligibility Criteria
Inclusion
- Postmenopausal women with osteoporosis
Exclusion
- Any therapies or products affecting bone turnover within 12 months of Screening.
- Bisphosphonate treatment \>1 month in total duration at any time in the past.
- In addition, patients must be bisphosphonate-treatment-free for at least 12 months prior to Screening.
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00365924
Start Date
December 1 2006
End Date
April 1 2008
Last Update
March 23 2009
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Buenos Aires, Argentina, C1055AAK
2
Pfizer Investigational Site
Buenos Aires, Argentina, C1428AQK
3
Pfizer Investigational Site
Capital Federal - Buenos Aires, Argentina, C1012AAP